FDA NDC
Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 61269-386
- Proprietary name
- Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
- Nonproprietary name
- Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
- Labeler
- H2-Pharma, LLC
- Dosage form
- CAPSULE
- Strength
- 140 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.